Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in JapanArticle Published on 2021-02-012023-07-11 Journal: Transfusion [Category] SARS, [키워드] binding coronavirus COVID-19 IVIG MERS neutralization SARS [DOI] 10.1111/trf.16161
Successful treatment of two Japanese ESRD cases with severe COVID-19 pneumonia중증 코로나19 폐렴을 동반한 일본 ESRD 사례 2건의 성공적인 치료Case Reports Published on 2021-02-012022-09-11 Journal: CEN case reports [Category] MERS, SARS, 진단, 치료제, [키워드] acute respiratory distress acute respiratory distress syndrome acute respiratory distress syndrome (ARDS) Admission anti-cytokine anti-cytokine therapy ARDS Clinical course cohort study coronavirus disease Coronavirus disease 2019 Coronavirus disease 2019 (COVID-19) COVID-19 COVID-19 pneumonia Diabetic diabetic nephropathy disease distress effective End-stage renal disease End-stage renal disease (ESRD) ESRD exhibited Hemodialysis high mortality rate ICU Immunoglobulin indicate infected with COVID-19 intensive care intensive care unit Intravenous immunoglobulin Intravenous immunoglobulin (IVIG) IVIG Japanese Maintenance hemodialysis mechanical ventilation nephropathy novel Novel coronavirus novel coronavirus disease Patient patients renal renal disease respiratory distress Respiratory distress syndrome Severe COVID-19 pneumonia syndrome Tocilizumab treated Treatment were infected with COVID-19 [DOI] 10.1007/s13730-020-00512-7 PMC 바로가기 [Article Type] Case Reports
Comparative Evaluation of the Treatment of COVID-19 with Multicriteria Decision-Making Techniques다기준 의사결정 기법을 통한 코로나19 치료의 비교 평가Comparative Study Published on 2021-01-222022-09-10 Journal: Journal of Healthcare Engineering [Category] 진단, 치료제, [키워드] addition administration age alternatives Analysis applied assigned Comparative complex coronavirus disease Coronavirus disease 2019 COVID-19 criteria drug effective evaluate evaluated Favipiravir Fever followed by FPV global pandemic healthcare Hydroxychloroquine Immunoglobulin include interleukin Intravenous immunoglobulin IVIG Kidney function Lopinavir Lopinavir/ritonavir management New objective outbreak plasma plasma exchange Pregnancy problem qualitative data Quantitative reported Result Ritonavir Side effects technique the disease to define Treatment treatment methods [DOI] 10.1155/2021/8864522 PMC 바로가기 [Article Type] Comparative Study
Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series길랭 바레 증후군과 COVID-19의 징후로서의 그 변종: 사례 보고 및 사례 시리즈에 대한 체계적인 검토Article Published on 2021-01-152022-09-11 Journal: Journal of the neurological sciences [Category] 변종, 유전자 메커니즘, [키워드] AIDP AMSAN Bickerstaff encephalitis both groups Case report case sery caused Clinical features CNS COVID-19 COVID-19 pandemic COVID-19 patients criteria database demographics Descriptive analysis diagnostic Erasmus focus GBS Google Scholar identify immunological in both group include Inflammatory IVIG knowledge Laboratory laboratory findings level 1 manifestation MFS not differ outcomes Patient patients Plasmapheresis report Research SARS-CoV-2 SARS-CoV-2 patient SARS-CoV-2 patients score searched systematic review Treatment two group two groups variant variants Wuhan Wuhan, China [DOI] 10.1016/j.jns.2020.117263 PMC 바로가기 [Article Type] Article
Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel이스라엘의 원발성 면역 결핍증 환자에 대한 COVID-19 유행병의 경미한 임상 영향Immunology Published on 2021-01-142022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 치료기술, [키워드] adaptive affected agammaglobulinemia assumed Asymptomatic Awareness clinical Clinical and laboratory data clinical impact component components coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 pandemic Critical Data collection disease genetic defect global pandemic human immunity immune pathway immune response immune system immunodeficiency Impact in some inborn errors of immunity include individual Infection innate cell interferon IVIG laboratory data lack minor not affected pandemic pathway Pathways Patient patients PID Population positive Primary Immunodeficiency Protective replacement therapy required respiratory risk SARS-CoV-2 second wave Self-isolation Severe acute respiratory syndrome severe acute respiratory syndrome-coronavirus-2 Signaling tested the patient therapy type I interferon virus detection was collected while [DOI] 10.3389/fimmu.2020.614086 PMC 바로가기 [Article Type] Immunology
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial중증 COVID-19 사례 관리에 대한 정맥 면역글로불린(IVIg)의 효과 평가: 무작위 대조 시험Randomized Controlled Trial Published on 2021-01-012022-09-11 Journal: International immunopharmacology [Category] SARS, 임상, 진단, 치료제, [키워드] Admission both groups Combination control group coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demographic data dose Effect Evaluating Factors group hospital Hospital admission Hospital stay Hydroxychloroquine ICU Immunoglobulin Infection intensive care unit intervention group Intravenous immunoglobulin IVIG Lopinavir Lopinavir/ritonavir management mechanical ventilation Mortality mortality rate no significant difference P-value pandemic Patient positive positive relationship Previous studies previous study pulmonary Pulmonary infection Pulmonary infection. Randomized controlled trial reducing Ritonavir severe cases severe COVID-19 significantly lower Support supportive care survivor Treatment two group two groups Viral Viral load were recorded [DOI] 10.1016/j.intimp.2020.107205 PMC 바로가기 [Article Type] Randomized Controlled Trial
Guillain-Barre Syndrome and COVID-19: A case report길랭-바레 증후군과 COVID-19: 사례 보고Case Reports Published on 2021-01-012022-09-12 Journal: Clinical neurology and neurosurgery [Category] MERS, 진단, [키워드] Case report COVID-19 Dysautonomia Guillain-barrè syndrome IVIG Patient polyneuropathies report SARS-CoV-2 viral infection [DOI] 10.1016/j.clineuro.2020.106413 PMC 바로가기 [Article Type] Case Reports
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysisCOVID-19 치료를 위한 약리학적 중재의 비교 효능 및 안전성: 체계적인 검토 및 네트워크 메타 분석Meta-Analysis Published on 2020-12-302022-08-13 Journal: PLoS Medicine [Category] Biology and Life Sciences, MERS, meta-analysis, 임상, [키워드] 1.26 95% CI 95% confidence interval Admission aggravation Alpha Anakinra analyses Analysis anti-inflammatory agent anti-inflammatory agents Asia assessment associations Azithromycin benefit Cardiac complications cardiac safety risk cardiac safety risks cardiac-impaired population cardiac-impaired populations carried categories category Causality certainty clinical clinical benefit clinical benefits Clinical outcome clinical settings clinical trial ClinicalTrials clinician Cochrane Library collected Combination Comparative controlled trials convalescent plasma coronavirus disease Coronavirus disease 2019 Corticosteroid Corticosteroids Course COVID-19 COVID-19 disease COVID-19 disease course COVID-19 treatments CRD42020186527 Critically ill Critically ill patient critically ill patients daclatasvir dataset determine development disease course drug effective Efficacy and safety eligibility criteria eligible Europe evaluate Evidence evidence of fatal cardiac complication fatal cardiac complications Google Scholar help heterogeneous High-dose Hospitalization hospitalized COVID-19 patients Hydroxychloroquine ICU Immunoglobulin information intensive care intensive care unit interferon interferon-alpha Intravenous immunoglobulin investigated itolizumab Ivermectin IVIG Level management mechanical ventilation medRxiv Meta-analysis Middle East mild patients moderate moderate to severe moderate/high evidence certainty Mortality mortality rate mortality rates Network meta-analysis NMA non-ICU non-ICU setting noncardiac serious adverse events North America Numerous observational studies observational study Odds ratio outcome Patient patients hospitalized pharmacological agent pharmacological intervention pharmacological interventions pharmacological management plasma Policy populations Potential treatment potential treatments progression PROSPERO provide QT prolongation QT prolongation incidence Randomized controlled trial Randomized controlled trials randomized trial randomized trials RCT RCTs recommendations reduce reduce COVID-19 aggravation reduce mortality rate reduced reflected registry Remdesivir Research researcher Result risk risk of bia RoB RoB2 ROBINS-I framework searched self-limiting disease Serious Adverse Event Serious Adverse Events severe COVID-19 patient severe disease severe pneumonia shown significantly sofosbuvir sofosbuvir plus daclatasvir South America SSRN standard care Study protocol supported systematic review systematic synthesis Tocilizumab translated Treatment treatment regimen viral clearance rate vulnerable population WHO WHO International Clinical Trials Registry Platform [DOI] 10.1371/journal.pmed.1003501 PMC 바로가기 [Article Type] Meta-Analysis
Role of Host Immune and Inflammatory Responses in COVID-19 Cases with Underlying Primary Immunodeficiency: A Review기저 면역 결핍이 있는 COVID-19 사례에서 숙주 면역 및 염증 반응의 역할: 검토Review Published on 2020-12-012022-09-12 Journal: Journal of interferon & cytokine research : the of [Category] MERS, 진단, [키워드] acute respiratory syndrome anti-infection Anti-inflammatory Antiviral characterized Comorbidities coronavirus Coronavirus disease 2019 COVID-19 cytokine release Cytokine release syndrome Cytokine storm Cytokine storm syndrome deficiency disease severity higher risk IFNAR2 Immune status immune system immunodeficiency immunomodulatory effects Inflammatory response innate immune innate immune activation Innate immunity interferon regulatory factor interferon signaling Intravenous immunoglobulin IVIG literature review outcome pandemic Patient patient population patients PID Primary Immunodeficiency protective effect protective factor question receptor response review role SARS-CoV-2 SARS-COV-2 infection severe COVID-19 severe infections Signaling Spread suppressed susceptible therapy TLR7 [DOI] 10.1089/jir.2020.0210 PMC 바로가기 [Article Type] Review
Encephalopathy associated with COVID-19 in a patient with multiple sclerosisCase Reports Published on 2020-12-012023-07-06 Journal: Journal of Neurovirology [Category] SARS, [키워드] COVID-19 Encephalopathy IVIG multiple sclerosis SARS-CoV-2 [DOI] 10.1007/s13365-020-00921-5 PMC 바로가기 [Article Type] Case Reports